References
- Martyn D, Meckley LM, Miyasato G, et al. Variation in hospital resource use and cost among surgical procedures using topical absorbable hemostats. Clinicoecon Outcomes Res 2015;7:567-74
- Shander A. Financial and clinical outcomes associated with surgical bleeding complications. Surgery 2007;142(4 Suppl):S20-S5
- Karthik S, Grayson AD, McCarron EE, et al. Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay. Ann Thorac Surg 2004;78:527-34
- Stokes ME, Ye X, Shah M, et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res 2011;11:135
- Alström U, Levine LÅ, Svedholm R. Cost analysis of re-exploration for bleeding after coronary artery bypass graft surgery. Br J Anaesth 2012;108:216-22
- Christensen MC, Krapf S, Kempel A, et al. Costs of excessive postoperative hemorrhage in cardiac surgery. J Thorac Cardiovasc Surg 2009;138:687-93
- Ministry of Health. Chikungunya, the preventive measures of the National Blood Center [Internet]. Rome, Italy: Ministry of Health; 2017. Available at: http://www.salute.gov.it/portale/news/p3_2_1_1_1.jsp?lingua=italiano&menu=notizie&p=dalministero&id = 3083
- Natour E, Suedkamp M, Dapunt OE. Assessment of the effect on blood loss and transfusion requirements when adding a polyethylene glycol sealant to the anastomotic closure of aortic procedures: a case-control analysis of 102 patients undergoing Bentall procedures. J Cardiothorac Surg 2012;7:105
- Vivacqua A, Koch CG, Yousuf AM, et al. Morbidity of bleeding after cardiac surgery: is it blood transfusion, reoperation for bleeding, or both? Ann Thorac Surg 2011;91:1780-90
- Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016. Eur J Anaesthesiol 2017;34:332-95
- Samudrala S. Topical hemostatic agents in surgery: a surgeon’s perspective. AORN J 2008;88:S2-S11
- Bracey A, Shander A, Aronson S, et al. The use of topical hemostatic agents in cardiothoracic surgery. Ann Thorac Surg 2017;104:353-60
- Achneck HE, Sileshi B, Jamiolkowski RM, et al. A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg 2010;251:217-28
- Schelling G, Block T, Blanke E, et al. The effectiveness of a fibrinogen-thrombin-collagen-based hemostatic agent in an experimental arterial bleeding model. Ann Surg 1987;205:432-5
- Lewis KM, Kuntze CE, Gulle H. Control of bleeding in surgical procedures: critical appraisal of HEMOPATCH (Sealing Hemostat). Med Devices (Auckl) 2016;9:1-10
- Ruggiero R, Docimo L, Tolone S, et al. Effectiveness of an advanced hemostatic pad combined with harmonic scalpel in thyroid surgery. A prospective study. Int J Surg 2016;28(Suppl 1):S17-S21
- Corral M, Ferko N, Hogan A, et al. A hospital cost analysis of a fibrin sealant patch in soft tissue and hepatic surgical bleeding. Clinicoecon Outcomes Res 2016;8:507
- Fingerhut A, Uranues S, Ettorre GM, et al. European initial hands-on experience with HEMOPATCH, a novel sealing hemostatic patch: application in general, gastrointestinal, biliopancreatic, cardiac, and urologic surgery. Surg Technol Int 2014;25:29-35
- Weltert L, D’Aleo S, Chirichilli I, et al. Prospective randomized clinical trial of HEMOPATCH topical sealant in cardiac surgery. Surg Technol Int 2016;29 [Epub ahead of print]
- Regione Lombardia Bollettino ufficiale. Determinazioni in ordine alla gestione del servizio socio sanitario regionale per l’esercizio 2015. Milano: Nuove Tariffe DRG; 2015. Delibera Giunta X/2989. Italian
- Natour E, Suedkamp M, Dapunt OE. Assessment of the effect on blood loss and transfusion requirements when adding a polyethylene glycol sealant to the anastomotic closure of aortic procedures: a case–control analysis of 102 patients undergoing Bentall procedures. J Cardiothoracic Surg 2012;7:105
- Conferenza Stato-Regioni. Indicazioni in merito al prezzo unitario di cessione, tra aziende sanitarie e tra regioni e province autonome, delle unità di sangue, dei suoi componenti e dei farmaci plasmaderivati prodotti in convenzione, nonché azioni di incentivazione dell’interscambio tra le aziende sanitarie all’interno della regione e tra le regioni. Regioni e le Province autonome di Trento e di Bolzano: Conferenza Stato-Regioni; 2015. Italian
- Instituto de Información Sanitaria. Registro de altas – CMBD. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2017. Spanish
- Servicio de Salud de Castilla-La Mancha. Diario Oficial de Castilla-La Mancha 267. Castilla-La Mancha: Gobierno de Castilla-La Mancha; 2008. Resolucion 1 diciembre 2008. Spanish
- Departament de Salut. Diari Oficial de la Generalitat de Catalunya 5167. Catalonia: Generalitat de Catalunya; 2008. Ordre SLT/325/2008. Spanish
- Conselleria de Sanitat Valencia. Catálogo de procedimientos de enfermería en hospitalización de día. Versión 2002. Valencia: Generalitat Valenciana; 2002. Spanish
- Agence Technique de l'Information sur l'Hospitilisation. Analyse de la base nationale hospitaliere. Lyon: PMSI; 2013. French
- Ministère des Solidarités et de la Santé. Relatif au tarif de cession des produits sanguins labiles, vrsion consolidee du 29/12/14. Paris: Journal Officiel de la République Française; 2017. French
- NHS National Tariff Payment System 2016/17 [Internet]. London: NHS England; 2016. Available at: https://www.gov.uk/government/publications/nhs-national-tariff-payment-system-201617
- NICE. Costing statement: Blood transfusion implementing the NICE guideline on blood transfusion (NG24). London: NICE; 2015
- Nobilio L, Fortuna D, Vizioli M, et al. Impact of regionalisation of cardiac surgery in Emilia-Romagna, Italy. J Epidemiol Commun Health 2004;58:97-102
- Stone GW, Clayton TC, Mehran R, et al. Impact of major bleeding and blood transfusions after cardiac surgery: analysis from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial. Am Heart J 2012;163:522-9